Indeed, de novo Caspase-8 expression has been reported in glioblastoma (GBM), compared to normal tissue, and its overexpression has been demonstrated to drive tumor aggressiveness and resistance to therapy in different ways [3–5]. This evidence concerns the gene CASP8 and glioblastoma.